Detalles de la búsqueda
1.
Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types.
mSphere
; 8(2): e0096221, 2023 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36926984
2.
Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants.
Hum Vaccin Immunother
; 18(6): 2105067, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35997582
3.
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9-45 years of age: A phase 3 open-label study.
Vaccine
; 40(23): 3263-3271, 2022 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35487814
4.
Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years.
Hum Vaccin Immunother
; 18(5): 2078626, 2022 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35853188
5.
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
Lancet Infect Dis
; 22(3): 413-425, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34780705
6.
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial.
Hum Vaccin Immunother
; 17(7): 1980-1985, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33844623
7.
Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up.
Hum Vaccin Immunother
; 17(4): 943-949, 2021 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33326342
8.
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in Chinese females aged 9 to 26 years: A phase 3, open-label, immunobridging study.
Vaccine
; 39(4): 760-766, 2021 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239228
9.
Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries.
EClinicalMedicine
; 23: 100401, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32637895
10.
Design of a long-term follow-up effectiveness, immunogenicity and safety study of women who received the 9-valent human papillomavirus vaccine.
Contemp Clin Trials
; 52: 54-61, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27777126
11.
The puromycin-sensitive aminopeptidase PAM-1 is required for meiotic exit and anteroposterior polarity in the one-cell Caenorhabditis elegans embryo.
Development
; 133(21): 4281-92, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17021038
Resultados
1 -
11
de 11
1
Próxima >
>>